Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record history adds a new revision label v3.6.6 and removes the previous label v3.6.5. This reflects an update to the page's versioning history without altering the underlying content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry for v3.6.5 was added to the record history, and the previous v3.6.4 entry was removed. This reflects an update to the study record metadata in the history log.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a new revision entry v3.6.4 and removed the previous revision v3.6.3 in the record history. This reflects an update to the study record versions on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry (v3.6.3) was added to the study's history, representing an update to the page’s record, while the previous revision (v3.6.2) was removed from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now includes a new revision entry: v3.6.2, replacing the previous v3.6.0 entry. This marks an updated version of the study record without changing its substantive details.SummaryDifference0.1%

- Check93 days agoChange DetectedEnrollment status changed to closed, indicating the study is no longer seeking participants. The record version was updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.7%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.